Iana H. Haralambieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iana H. Haralambieva has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ivan Mitov
Med Univ Sofia, Med Fac, Dept Med Microbiol, 2 Zdrave St, Sofia 1431, Bulgaria
2 shared publications Dragomir P. Petrov
Department of Microbiology, Medical University, Zdrave 2 str., 1431 Sofia, Bulgaria
1 shared publicationIanko D Iankov
Departments of Microbiology1 and Chemistry and Biochemistry2, Medical University, Zdrave 2 str., 1431 Sofia, Bulgaria
1 shared publication- Ianko D. Iankov
Department of Microbiology, Medical University of Sofia, Zdrave 2 Street, 1431 Sofia, Bulgaria
1 shared publication - Ivan V. Mladenov
Department of Biology, Medical University, Zdrave 2 str., 1431 Sofia, Bulgaria
1 shared publication Petya V Ivanova
Departments of Microbiology1 and Chemistry and Biochemistry2, Medical University, Zdrave 2 str., 1431 Sofia, Bulgaria
1 shared publication
Latest Publications
- Open Access
- 1 December 2004
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 53 (12) , 1187-1193
Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4
Chlamydophila pneumoniae, an obligately intracellular Gram-negative bacterium and a common causative agent of respiratory tract infections, has been implicated in the induction and progression of atherosclerosis and coronary artery disease. In this study, the signalling mechanism of C. pneumoniae in human fibroblasts, a prominent cell population in chronic inflammation and persistent infection, contributing to plaque formation, was investigated. C. pneumoniae elementary bodies were demonstrated to up-regulate the phosphorylation of p44/p42 mitogen-activated protein kinase (MAPK) in human fibroblasts. The effect was independent of the chlamydial lipopolysaccharide and was likely to be mediated by a heat-labile chlamydial protein. Furthermore, an anti-Toll-like receptor 4 (TLR4) antibody was shown to abolish C. pneumoniae-induced cell activation, whereas an anti-TLR2 antibody had no effect, indicating the role of TLR4 in p44/p42 MAPK activation. Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 and phosphodiesterase 4 (PDE 4) inhibitor Rolipram enhanced C. pneumoniae-induced MAPK phosphorylation and attenuated C. pneumoniae infectivity in vitro. Together the results indicate that C. pneumoniae triggers rapid TLR4-mediated p44/p42 MAPK activation in human fibroblasts and chemical enhancement of MAPK phosphorylation modulates in vitro infection at the molecular level.
- 1 December 2004
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 53 (12) , 1187-1193
Open AccessChlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4
Chlamydophila pneumoniae, an obligately intracellular Gram-negative bacterium and a common causative agent of respiratory tract infections, has been implicated in the induction and progression of atherosclerosis and coronary artery disease. In this study, the signalling mechanism of C. pneumoniae in human fibroblasts, a prominent cell population in chronic inflammation and persistent infection, contributing to plaque formation, was investigated. C. pneumoniae elementary bodies were demonstrated to up-regulate the phosphorylation of p44/p42 mitogen-activated protein kinase (MAPK) in human fibroblasts. The effect was independent of the chlamydial lipopolysaccharide and was likely to be mediated by a heat-labile chlamydial protein. Furthermore, an anti-Toll-like receptor 4 (TLR4) antibody was shown to abolish C. pneumoniae-induced cell activation, whereas an anti-TLR2 antibody had no effect, indicating the role of TLR4 in p44/p42 MAPK activation. Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 and phosphodiesterase 4 (PDE 4) inhibitor Rolipram enhanced C. pneumoniae-induced MAPK phosphorylation and attenuated C. pneumoniae infectivity in vitro. Together the results indicate that C. pneumoniae triggers rapid TLR4-mediated p44/p42 MAPK activation in human fibroblasts and chemical enhancement of MAPK phosphorylation modulates in vitro infection at the molecular level.
- 3 June 2002
- Published by Wiley in FEMS Immunology & Medical Microbiology
- Vol. 33 (2) , 107-113
Production and characterization of monoclonal immunoglobulin A antibodies directed against Salmonella H:g,m flagellar antigen
- 3 June 2002
- Published by Wiley in FEMS Immunology & Medical Microbiology
- Vol. 33 (2) , 107-113
Production and characterization of monoclonal immunoglobulin A antibodies directed against Salmonella H:g,m flagellar antigen